|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,000.56 |
3.35% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$63,929.40 |
3.06% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$54,800.01 |
2.62% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$51,680.51 |
2.47% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$49,148.54 |
2.35% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$49,177.60 |
2.35% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,444.54 |
2.27% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$46,892.46 |
2.24% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$44,910.99 |
2.15% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$44,700.48 |
2.14% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,571.29 |
2.13% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,439.41 |
2.13% |
| Waters Corporation |
WAT |
941848103 |
120 |
$44,486.40 |
2.13% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,381.14 |
2.12% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,379.40 |
2.12% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,133.77 |
2.11% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$43,853.04 |
2.10% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,974.36 |
2.10% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,544.72 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$43,121.33 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$43,037.28 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,570.44 |
2.04% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$41,530.96 |
1.99% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$40,950.45 |
1.96% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$41,069.19 |
1.96% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$40,288.38 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$40,282.04 |
1.93% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$40,217.95 |
1.92% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$39,642.74 |
1.90% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$39,494.80 |
1.89% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$39,355.80 |
1.88% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$39,084.20 |
1.87% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$39,095.54 |
1.87% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$38,708.87 |
1.85% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$38,544.80 |
1.84% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,459.35 |
1.84% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,971.57 |
1.82% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$37,903.08 |
1.81% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,549.99 |
1.80% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,656.47 |
1.75% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$36,467.19 |
1.74% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,440.06 |
1.74% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$35,130.24 |
1.68% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,859.58 |
1.67% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$34,778.29 |
1.66% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$32,899.30 |
1.57% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$32,487.87 |
1.55% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$32,071.23 |
1.53% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,657.53 |
1.47% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$26,717.88 |
1.28% |
| US Dollar |
$USD |
|
2,738 |
$2,737.77 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|